Bridgeway Capital Management, LLC Abb Vie Inc. Transaction History

Bridgeway Capital Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $41,280 - $46,491	-300 Reduced 16.14%	1,559 $241,000
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $2.04 Million - $2.27 Million	-19,400 Reduced 91.26%	1,859 $209,000
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $1.63 Million - $2.21 Million	-20,300 Reduced 48.85%	21,259 $2.28 Million
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $13.4 Million - $15.8 Million	-156,300 Reduced 79.0%	41,559 $3.64 Million
Q2 2020 Aug 31, 2020	BUY	$73.37 - $98.18 $454,894 - $608,716	6,200 Added 3.23%	197,859 $19.4 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $14.1 Million - $18.8 Million	191,659 New	191,659 $18.8 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $7.68 Million - $9.48 Million	-98,700 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $4.45 Million - $4.95 Million	-50,100 Reduced 33.67%	98,700 $9.34 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $53,868 - $63,738	600 Added 0.4%	148,800 $13.8 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $4.28 Million - $5.73 Million	46,500 Added 45.72%	148,200 $14 Million
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $9.11 Million - $9.99 Million	101,700	101,700 $9.84 Million

4,095

1.28B

16.7M

15M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $357B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.